nodes	percent_of_prediction	percent_of_DWPC	metapath
Flutamide—AHR—pancreatic cancer	0.467	1	CbGaD
Flutamide—CYP1B1—Tamoxifen—pancreatic cancer	0.0624	0.152	CbGbCtD
Flutamide—CYP1B1—Erlotinib—pancreatic cancer	0.0531	0.129	CbGbCtD
Flutamide—CYP1B1—Docetaxel—pancreatic cancer	0.0351	0.0856	CbGbCtD
Flutamide—CYP1A1—Dacarbazine—pancreatic cancer	0.0344	0.0839	CbGbCtD
Flutamide—CYP1A1—Tamoxifen—pancreatic cancer	0.0274	0.0667	CbGbCtD
Flutamide—CYP1B1—Doxorubicin—pancreatic cancer	0.0262	0.0638	CbGbCtD
Flutamide—CYP1A1—Erlotinib—pancreatic cancer	0.0233	0.0567	CbGbCtD
Flutamide—CYP3A5—Tamoxifen—pancreatic cancer	0.0164	0.0401	CbGbCtD
Flutamide—CYP1A2—Dacarbazine—pancreatic cancer	0.0154	0.0375	CbGbCtD
Flutamide—CYP3A5—Erlotinib—pancreatic cancer	0.014	0.0341	CbGbCtD
Flutamide—CYP2C19—Tamoxifen—pancreatic cancer	0.0133	0.0323	CbGbCtD
Flutamide—CYP3A5—Irinotecan—pancreatic cancer	0.0126	0.0308	CbGbCtD
Flutamide—CYP1A2—Tamoxifen—pancreatic cancer	0.0122	0.0298	CbGbCtD
Flutamide—CYP1A2—Erlotinib—pancreatic cancer	0.0104	0.0253	CbGbCtD
Flutamide—CYP3A5—Docetaxel—pancreatic cancer	0.00925	0.0225	CbGbCtD
Flutamide—CYP3A5—Sunitinib—pancreatic cancer	0.00921	0.0224	CbGbCtD
Flutamide—CYP1A2—Fluorouracil—pancreatic cancer	0.00902	0.022	CbGbCtD
Flutamide—CYP3A4—Tamoxifen—pancreatic cancer	0.00641	0.0156	CbGbCtD
Flutamide—CYP3A4—Erlotinib—pancreatic cancer	0.00545	0.0133	CbGbCtD
Flutamide—CYP3A4—Irinotecan—pancreatic cancer	0.00492	0.012	CbGbCtD
Flutamide—CYP3A4—Docetaxel—pancreatic cancer	0.00361	0.00879	CbGbCtD
Flutamide—CYP3A4—Sunitinib—pancreatic cancer	0.00359	0.00875	CbGbCtD
Flutamide—CYP3A4—Doxorubicin—pancreatic cancer	0.00269	0.00655	CbGbCtD
Flutamide—Pulmonary embolism—Epirubicin—pancreatic cancer	0.000202	0.00226	CcSEcCtD
Flutamide—Hypertension—Sunitinib—pancreatic cancer	0.000198	0.00222	CcSEcCtD
Flutamide—Insomnia—Tamoxifen—pancreatic cancer	0.000198	0.00221	CcSEcCtD
Flutamide—Ulcer—Doxorubicin—pancreatic cancer	0.000197	0.00221	CcSEcCtD
Flutamide—Cystitis noninfective—Epirubicin—pancreatic cancer	0.000197	0.0022	CcSEcCtD
Flutamide—Insomnia—Erlotinib—pancreatic cancer	0.000196	0.00219	CcSEcCtD
Flutamide—Toxic epidermal necrolysis—Docetaxel—pancreatic cancer	0.000195	0.00219	CcSEcCtD
Flutamide—Aspartate aminotransferase increased—Docetaxel—pancreatic cancer	0.000195	0.00219	CcSEcCtD
Flutamide—Cystitis—Epirubicin—pancreatic cancer	0.000195	0.00218	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.000194	0.00217	CcSEcCtD
Flutamide—Blood urea increased—Epirubicin—pancreatic cancer	0.00019	0.00213	CcSEcCtD
Flutamide—Decreased appetite—Tamoxifen—pancreatic cancer	0.00019	0.00213	CcSEcCtD
Flutamide—Fatigue—Tamoxifen—pancreatic cancer	0.000189	0.00211	CcSEcCtD
Flutamide—Decreased appetite—Erlotinib—pancreatic cancer	0.000188	0.0021	CcSEcCtD
Flutamide—Oedema—Sunitinib—pancreatic cancer	0.000187	0.0021	CcSEcCtD
Flutamide—Constipation—Tamoxifen—pancreatic cancer	0.000187	0.00209	CcSEcCtD
Flutamide—Pulmonary embolism—Doxorubicin—pancreatic cancer	0.000187	0.00209	CcSEcCtD
Flutamide—Fatigue—Erlotinib—pancreatic cancer	0.000187	0.00209	CcSEcCtD
Flutamide—Constipation—Erlotinib—pancreatic cancer	0.000185	0.00207	CcSEcCtD
Flutamide—Erythema—Gemcitabine—pancreatic cancer	0.000184	0.00206	CcSEcCtD
Flutamide—Thrombocytopenia—Sunitinib—pancreatic cancer	0.000183	0.00205	CcSEcCtD
Flutamide—Ecchymosis—Epirubicin—pancreatic cancer	0.000182	0.00204	CcSEcCtD
Flutamide—Neoplasm—Epirubicin—pancreatic cancer	0.000182	0.00204	CcSEcCtD
Flutamide—Bladder pain—Epirubicin—pancreatic cancer	0.000182	0.00204	CcSEcCtD
Flutamide—Cystitis noninfective—Doxorubicin—pancreatic cancer	0.000182	0.00204	CcSEcCtD
Flutamide—Skin disorder—Sunitinib—pancreatic cancer	0.000182	0.00204	CcSEcCtD
Flutamide—Erythema—Fluorouracil—pancreatic cancer	0.000181	0.00203	CcSEcCtD
Flutamide—Cystitis—Doxorubicin—pancreatic cancer	0.00018	0.00202	CcSEcCtD
Flutamide—Anorexia—Sunitinib—pancreatic cancer	0.000179	0.002	CcSEcCtD
Flutamide—Blood urea increased—Doxorubicin—pancreatic cancer	0.000176	0.00197	CcSEcCtD
Flutamide—Ill-defined disorder—Irinotecan—pancreatic cancer	0.000175	0.00196	CcSEcCtD
Flutamide—Anaemia—Irinotecan—pancreatic cancer	0.000175	0.00196	CcSEcCtD
Flutamide—Ill-defined disorder—Gemcitabine—pancreatic cancer	0.000171	0.00191	CcSEcCtD
Flutamide—Malaise—Irinotecan—pancreatic cancer	0.000171	0.00191	CcSEcCtD
Flutamide—Anaemia—Gemcitabine—pancreatic cancer	0.00017	0.0019	CcSEcCtD
Flutamide—Insomnia—Sunitinib—pancreatic cancer	0.000169	0.0019	CcSEcCtD
Flutamide—Leukopenia—Irinotecan—pancreatic cancer	0.000169	0.00189	CcSEcCtD
Flutamide—Ecchymosis—Doxorubicin—pancreatic cancer	0.000169	0.00189	CcSEcCtD
Flutamide—Bladder pain—Doxorubicin—pancreatic cancer	0.000169	0.00189	CcSEcCtD
Flutamide—Neoplasm—Doxorubicin—pancreatic cancer	0.000169	0.00189	CcSEcCtD
Flutamide—Diabetes mellitus—Epirubicin—pancreatic cancer	0.000168	0.00188	CcSEcCtD
Flutamide—Anaemia—Fluorouracil—pancreatic cancer	0.000167	0.00187	CcSEcCtD
Flutamide—Malaise—Gemcitabine—pancreatic cancer	0.000166	0.00186	CcSEcCtD
Flutamide—Leukopenia—Gemcitabine—pancreatic cancer	0.000165	0.00184	CcSEcCtD
Flutamide—Hypertension—Irinotecan—pancreatic cancer	0.000163	0.00183	CcSEcCtD
Flutamide—Jaundice—Docetaxel—pancreatic cancer	0.000163	0.00182	CcSEcCtD
Flutamide—Decreased appetite—Sunitinib—pancreatic cancer	0.000163	0.00182	CcSEcCtD
Flutamide—Leukopenia—Fluorouracil—pancreatic cancer	0.000162	0.00181	CcSEcCtD
Flutamide—Fatigue—Sunitinib—pancreatic cancer	0.000162	0.00181	CcSEcCtD
Flutamide—Constipation—Sunitinib—pancreatic cancer	0.00016	0.00179	CcSEcCtD
Flutamide—Discomfort—Irinotecan—pancreatic cancer	0.000159	0.00178	CcSEcCtD
Flutamide—Hypertension—Gemcitabine—pancreatic cancer	0.000159	0.00178	CcSEcCtD
Flutamide—Asthenia—Tamoxifen—pancreatic cancer	0.000157	0.00176	CcSEcCtD
Flutamide—Hot flush—Epirubicin—pancreatic cancer	0.000156	0.00175	CcSEcCtD
Flutamide—Increased appetite—Epirubicin—pancreatic cancer	0.000156	0.00174	CcSEcCtD
Flutamide—Diabetes mellitus—Doxorubicin—pancreatic cancer	0.000156	0.00174	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.000156	0.00174	CcSEcCtD
Flutamide—Confusional state—Irinotecan—pancreatic cancer	0.000156	0.00174	CcSEcCtD
Flutamide—Asthenia—Erlotinib—pancreatic cancer	0.000155	0.00174	CcSEcCtD
Flutamide—Menopausal symptoms—Epirubicin—pancreatic cancer	0.000155	0.00174	CcSEcCtD
Flutamide—Discomfort—Gemcitabine—pancreatic cancer	0.000155	0.00173	CcSEcCtD
Flutamide—Pruritus—Tamoxifen—pancreatic cancer	0.000155	0.00173	CcSEcCtD
Flutamide—Oedema—Irinotecan—pancreatic cancer	0.000154	0.00173	CcSEcCtD
Flutamide—Dermatitis bullous—Epirubicin—pancreatic cancer	0.000153	0.00171	CcSEcCtD
Flutamide—Pruritus—Erlotinib—pancreatic cancer	0.000153	0.00171	CcSEcCtD
Flutamide—Discomfort—Fluorouracil—pancreatic cancer	0.000152	0.0017	CcSEcCtD
Flutamide—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000151	0.00169	CcSEcCtD
Flutamide—Oedema—Gemcitabine—pancreatic cancer	0.00015	0.00168	CcSEcCtD
Flutamide—Hepatitis—Docetaxel—pancreatic cancer	0.00015	0.00168	CcSEcCtD
Flutamide—Diarrhoea—Tamoxifen—pancreatic cancer	0.00015	0.00167	CcSEcCtD
Flutamide—Confusional state—Fluorouracil—pancreatic cancer	0.000149	0.00167	CcSEcCtD
Flutamide—Diarrhoea—Erlotinib—pancreatic cancer	0.000148	0.00166	CcSEcCtD
Flutamide—Oedema peripheral—Docetaxel—pancreatic cancer	0.000148	0.00165	CcSEcCtD
Flutamide—Oedema—Fluorouracil—pancreatic cancer	0.000148	0.00165	CcSEcCtD
Flutamide—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000147	0.00165	CcSEcCtD
Flutamide—Anorexia—Irinotecan—pancreatic cancer	0.000147	0.00165	CcSEcCtD
Flutamide—Skin disorder—Gemcitabine—pancreatic cancer	0.000146	0.00163	CcSEcCtD
Flutamide—Hot flush—Doxorubicin—pancreatic cancer	0.000145	0.00162	CcSEcCtD
Flutamide—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000145	0.00162	CcSEcCtD
Flutamide—Dizziness—Tamoxifen—pancreatic cancer	0.000145	0.00162	CcSEcCtD
Flutamide—Increased appetite—Doxorubicin—pancreatic cancer	0.000144	0.00161	CcSEcCtD
Flutamide—Menopausal symptoms—Doxorubicin—pancreatic cancer	0.000144	0.00161	CcSEcCtD
Flutamide—Anorexia—Gemcitabine—pancreatic cancer	0.000143	0.0016	CcSEcCtD
Flutamide—Dizziness—Erlotinib—pancreatic cancer	0.000143	0.0016	CcSEcCtD
Flutamide—Dermatitis bullous—Doxorubicin—pancreatic cancer	0.000142	0.00159	CcSEcCtD
Flutamide—Anorexia—Fluorouracil—pancreatic cancer	0.000141	0.00158	CcSEcCtD
Flutamide—Insomnia—Irinotecan—pancreatic cancer	0.00014	0.00156	CcSEcCtD
Flutamide—Vomiting—Tamoxifen—pancreatic cancer	0.000139	0.00156	CcSEcCtD
Flutamide—Rash—Tamoxifen—pancreatic cancer	0.000138	0.00154	CcSEcCtD
Flutamide—Dermatitis—Tamoxifen—pancreatic cancer	0.000138	0.00154	CcSEcCtD
Flutamide—Vomiting—Erlotinib—pancreatic cancer	0.000138	0.00154	CcSEcCtD
Flutamide—Somnolence—Irinotecan—pancreatic cancer	0.000137	0.00153	CcSEcCtD
Flutamide—Headache—Tamoxifen—pancreatic cancer	0.000137	0.00153	CcSEcCtD
Flutamide—Rash—Erlotinib—pancreatic cancer	0.000136	0.00153	CcSEcCtD
Flutamide—Dermatitis—Erlotinib—pancreatic cancer	0.000136	0.00153	CcSEcCtD
Flutamide—Insomnia—Gemcitabine—pancreatic cancer	0.000136	0.00152	CcSEcCtD
Flutamide—Headache—Erlotinib—pancreatic cancer	0.000136	0.00152	CcSEcCtD
Flutamide—Asthenia—Sunitinib—pancreatic cancer	0.000134	0.0015	CcSEcCtD
Flutamide—Decreased appetite—Irinotecan—pancreatic cancer	0.000134	0.0015	CcSEcCtD
Flutamide—Insomnia—Fluorouracil—pancreatic cancer	0.000134	0.0015	CcSEcCtD
Flutamide—Somnolence—Gemcitabine—pancreatic cancer	0.000134	0.00149	CcSEcCtD
Flutamide—Fatigue—Irinotecan—pancreatic cancer	0.000133	0.00149	CcSEcCtD
Flutamide—Pruritus—Sunitinib—pancreatic cancer	0.000133	0.00148	CcSEcCtD
Flutamide—Constipation—Irinotecan—pancreatic cancer	0.000132	0.00148	CcSEcCtD
Flutamide—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.000132	0.00147	CcSEcCtD
Flutamide—Aspartate aminotransferase increased—Epirubicin—pancreatic cancer	0.000132	0.00147	CcSEcCtD
Flutamide—Somnolence—Fluorouracil—pancreatic cancer	0.000131	0.00147	CcSEcCtD
Flutamide—Erythema—Docetaxel—pancreatic cancer	0.000131	0.00146	CcSEcCtD
Flutamide—Decreased appetite—Gemcitabine—pancreatic cancer	0.000131	0.00146	CcSEcCtD
Flutamide—Nausea—Tamoxifen—pancreatic cancer	0.00013	0.00145	CcSEcCtD
Flutamide—Fatigue—Gemcitabine—pancreatic cancer	0.00013	0.00145	CcSEcCtD
Flutamide—Constipation—Gemcitabine—pancreatic cancer	0.000129	0.00144	CcSEcCtD
Flutamide—Nausea—Erlotinib—pancreatic cancer	0.000129	0.00144	CcSEcCtD
Flutamide—Decreased appetite—Fluorouracil—pancreatic cancer	0.000128	0.00144	CcSEcCtD
Flutamide—Diarrhoea—Sunitinib—pancreatic cancer	0.000128	0.00143	CcSEcCtD
Flutamide—Feeling abnormal—Irinotecan—pancreatic cancer	0.000127	0.00142	CcSEcCtD
Flutamide—Dizziness—Sunitinib—pancreatic cancer	0.000124	0.00139	CcSEcCtD
Flutamide—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000124	0.00139	CcSEcCtD
Flutamide—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000122	0.00136	CcSEcCtD
Flutamide—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.000122	0.00136	CcSEcCtD
Flutamide—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000122	0.00136	CcSEcCtD
Flutamide—Anaemia—Docetaxel—pancreatic cancer	0.000121	0.00135	CcSEcCtD
Flutamide—Vomiting—Sunitinib—pancreatic cancer	0.000119	0.00133	CcSEcCtD
Flutamide—Rash—Sunitinib—pancreatic cancer	0.000118	0.00132	CcSEcCtD
Flutamide—Dermatitis—Sunitinib—pancreatic cancer	0.000118	0.00132	CcSEcCtD
Flutamide—Headache—Sunitinib—pancreatic cancer	0.000117	0.00131	CcSEcCtD
Flutamide—Leukopenia—Docetaxel—pancreatic cancer	0.000117	0.00131	CcSEcCtD
Flutamide—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000115	0.00129	CcSEcCtD
Flutamide—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000114	0.00128	CcSEcCtD
Flutamide—Hypertension—Docetaxel—pancreatic cancer	0.000113	0.00126	CcSEcCtD
Flutamide—Drowsiness—Epirubicin—pancreatic cancer	0.000113	0.00126	CcSEcCtD
Flutamide—Nausea—Sunitinib—pancreatic cancer	0.000111	0.00124	CcSEcCtD
Flutamide—Asthenia—Irinotecan—pancreatic cancer	0.000111	0.00124	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000111	0.00124	CcSEcCtD
Flutamide—Jaundice—Epirubicin—pancreatic cancer	0.00011	0.00123	CcSEcCtD
Flutamide—Asthenia—Gemcitabine—pancreatic cancer	0.000108	0.00121	CcSEcCtD
Flutamide—Haematuria—Epirubicin—pancreatic cancer	0.000108	0.0012	CcSEcCtD
Flutamide—Confusional state—Docetaxel—pancreatic cancer	0.000108	0.0012	CcSEcCtD
Flutamide—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000107	0.0012	CcSEcCtD
Flutamide—Oedema—Docetaxel—pancreatic cancer	0.000107	0.00119	CcSEcCtD
Flutamide—Pruritus—Gemcitabine—pancreatic cancer	0.000106	0.00119	CcSEcCtD
Flutamide—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000106	0.00118	CcSEcCtD
Flutamide—Diarrhoea—Irinotecan—pancreatic cancer	0.000106	0.00118	CcSEcCtD
Flutamide—Pruritus—Fluorouracil—pancreatic cancer	0.000105	0.00117	CcSEcCtD
Flutamide—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000104	0.00117	CcSEcCtD
Flutamide—Drowsiness—Doxorubicin—pancreatic cancer	0.000104	0.00117	CcSEcCtD
Flutamide—Skin disorder—Docetaxel—pancreatic cancer	0.000104	0.00116	CcSEcCtD
Flutamide—Diarrhoea—Gemcitabine—pancreatic cancer	0.000103	0.00115	CcSEcCtD
Flutamide—Dizziness—Irinotecan—pancreatic cancer	0.000102	0.00114	CcSEcCtD
Flutamide—Jaundice—Doxorubicin—pancreatic cancer	0.000102	0.00114	CcSEcCtD
Flutamide—Anorexia—Docetaxel—pancreatic cancer	0.000102	0.00114	CcSEcCtD
Flutamide—Hepatitis—Epirubicin—pancreatic cancer	0.000101	0.00113	CcSEcCtD
Flutamide—Diarrhoea—Fluorouracil—pancreatic cancer	0.000101	0.00113	CcSEcCtD
Flutamide—Oedema peripheral—Epirubicin—pancreatic cancer	9.98e-05	0.00112	CcSEcCtD
Flutamide—Haematuria—Doxorubicin—pancreatic cancer	9.95e-05	0.00111	CcSEcCtD
Flutamide—Vomiting—Irinotecan—pancreatic cancer	9.81e-05	0.0011	CcSEcCtD
Flutamide—Dizziness—Fluorouracil—pancreatic cancer	9.77e-05	0.00109	CcSEcCtD
Flutamide—Rash—Irinotecan—pancreatic cancer	9.73e-05	0.00109	CcSEcCtD
Flutamide—Dermatitis—Irinotecan—pancreatic cancer	9.72e-05	0.00109	CcSEcCtD
Flutamide—Headache—Irinotecan—pancreatic cancer	9.67e-05	0.00108	CcSEcCtD
Flutamide—Insomnia—Docetaxel—pancreatic cancer	9.65e-05	0.00108	CcSEcCtD
Flutamide—Vomiting—Gemcitabine—pancreatic cancer	9.56e-05	0.00107	CcSEcCtD
Flutamide—Somnolence—Docetaxel—pancreatic cancer	9.48e-05	0.00106	CcSEcCtD
Flutamide—Rash—Gemcitabine—pancreatic cancer	9.48e-05	0.00106	CcSEcCtD
Flutamide—Dermatitis—Gemcitabine—pancreatic cancer	9.47e-05	0.00106	CcSEcCtD
Flutamide—Headache—Gemcitabine—pancreatic cancer	9.42e-05	0.00105	CcSEcCtD
Flutamide—Vomiting—Fluorouracil—pancreatic cancer	9.4e-05	0.00105	CcSEcCtD
Flutamide—Hepatitis—Doxorubicin—pancreatic cancer	9.37e-05	0.00105	CcSEcCtD
Flutamide—Rash—Fluorouracil—pancreatic cancer	9.32e-05	0.00104	CcSEcCtD
Flutamide—Dermatitis—Fluorouracil—pancreatic cancer	9.31e-05	0.00104	CcSEcCtD
Flutamide—Decreased appetite—Docetaxel—pancreatic cancer	9.27e-05	0.00104	CcSEcCtD
Flutamide—Headache—Fluorouracil—pancreatic cancer	9.26e-05	0.00104	CcSEcCtD
Flutamide—Oedema peripheral—Doxorubicin—pancreatic cancer	9.23e-05	0.00103	CcSEcCtD
Flutamide—Fatigue—Docetaxel—pancreatic cancer	9.2e-05	0.00103	CcSEcCtD
Flutamide—Nausea—Irinotecan—pancreatic cancer	9.17e-05	0.00103	CcSEcCtD
Flutamide—Constipation—Docetaxel—pancreatic cancer	9.12e-05	0.00102	CcSEcCtD
Flutamide—Nausea—Gemcitabine—pancreatic cancer	8.93e-05	0.000999	CcSEcCtD
Flutamide—Erythema—Epirubicin—pancreatic cancer	8.82e-05	0.000986	CcSEcCtD
Flutamide—Feeling abnormal—Docetaxel—pancreatic cancer	8.79e-05	0.000983	CcSEcCtD
Flutamide—Nausea—Fluorouracil—pancreatic cancer	8.78e-05	0.000982	CcSEcCtD
Flutamide—Tension—Epirubicin—pancreatic cancer	8.65e-05	0.000968	CcSEcCtD
Flutamide—Nervousness—Epirubicin—pancreatic cancer	8.56e-05	0.000958	CcSEcCtD
Flutamide—Ill-defined disorder—Epirubicin—pancreatic cancer	8.18e-05	0.000915	CcSEcCtD
Flutamide—Erythema—Doxorubicin—pancreatic cancer	8.16e-05	0.000913	CcSEcCtD
Flutamide—Anaemia—Epirubicin—pancreatic cancer	8.15e-05	0.000912	CcSEcCtD
Flutamide—Tension—Doxorubicin—pancreatic cancer	8e-05	0.000896	CcSEcCtD
Flutamide—Malaise—Epirubicin—pancreatic cancer	7.95e-05	0.000889	CcSEcCtD
Flutamide—Nervousness—Doxorubicin—pancreatic cancer	7.92e-05	0.000886	CcSEcCtD
Flutamide—Leukopenia—Epirubicin—pancreatic cancer	7.89e-05	0.000883	CcSEcCtD
Flutamide—Asthenia—Docetaxel—pancreatic cancer	7.65e-05	0.000856	CcSEcCtD
Flutamide—Hypertension—Epirubicin—pancreatic cancer	7.61e-05	0.000852	CcSEcCtD
Flutamide—Ill-defined disorder—Doxorubicin—pancreatic cancer	7.57e-05	0.000847	CcSEcCtD
Flutamide—Pruritus—Docetaxel—pancreatic cancer	7.55e-05	0.000844	CcSEcCtD
Flutamide—Anaemia—Doxorubicin—pancreatic cancer	7.54e-05	0.000843	CcSEcCtD
Flutamide—Anxiety—Epirubicin—pancreatic cancer	7.48e-05	0.000837	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	7.45e-05	0.000834	CcSEcCtD
Flutamide—Discomfort—Epirubicin—pancreatic cancer	7.42e-05	0.00083	CcSEcCtD
Flutamide—Malaise—Doxorubicin—pancreatic cancer	7.36e-05	0.000823	CcSEcCtD
Flutamide—Leukopenia—Doxorubicin—pancreatic cancer	7.3e-05	0.000817	CcSEcCtD
Flutamide—Diarrhoea—Docetaxel—pancreatic cancer	7.3e-05	0.000817	CcSEcCtD
Flutamide—Confusional state—Epirubicin—pancreatic cancer	7.25e-05	0.000812	CcSEcCtD
Flutamide—Oedema—Epirubicin—pancreatic cancer	7.19e-05	0.000805	CcSEcCtD
Flutamide—Dizziness—Docetaxel—pancreatic cancer	7.05e-05	0.000789	CcSEcCtD
Flutamide—Thrombocytopenia—Epirubicin—pancreatic cancer	7.04e-05	0.000788	CcSEcCtD
Flutamide—Hypertension—Doxorubicin—pancreatic cancer	7.04e-05	0.000788	CcSEcCtD
Flutamide—Skin disorder—Epirubicin—pancreatic cancer	6.99e-05	0.000782	CcSEcCtD
Flutamide—Anxiety—Doxorubicin—pancreatic cancer	6.92e-05	0.000774	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	6.9e-05	0.000772	CcSEcCtD
Flutamide—Discomfort—Doxorubicin—pancreatic cancer	6.86e-05	0.000768	CcSEcCtD
Flutamide—Anorexia—Epirubicin—pancreatic cancer	6.86e-05	0.000767	CcSEcCtD
Flutamide—Vomiting—Docetaxel—pancreatic cancer	6.78e-05	0.000759	CcSEcCtD
Flutamide—Rash—Docetaxel—pancreatic cancer	6.73e-05	0.000752	CcSEcCtD
Flutamide—Dermatitis—Docetaxel—pancreatic cancer	6.72e-05	0.000752	CcSEcCtD
Flutamide—Confusional state—Doxorubicin—pancreatic cancer	6.71e-05	0.000751	CcSEcCtD
Flutamide—Headache—Docetaxel—pancreatic cancer	6.68e-05	0.000748	CcSEcCtD
Flutamide—Oedema—Doxorubicin—pancreatic cancer	6.66e-05	0.000745	CcSEcCtD
Flutamide—Thrombocytopenia—Doxorubicin—pancreatic cancer	6.52e-05	0.000729	CcSEcCtD
Flutamide—Insomnia—Epirubicin—pancreatic cancer	6.51e-05	0.000728	CcSEcCtD
Flutamide—Skin disorder—Doxorubicin—pancreatic cancer	6.47e-05	0.000723	CcSEcCtD
Flutamide—Somnolence—Epirubicin—pancreatic cancer	6.4e-05	0.000716	CcSEcCtD
Flutamide—Anorexia—Doxorubicin—pancreatic cancer	6.35e-05	0.00071	CcSEcCtD
Flutamide—Nausea—Docetaxel—pancreatic cancer	6.34e-05	0.000709	CcSEcCtD
Flutamide—Decreased appetite—Epirubicin—pancreatic cancer	6.25e-05	0.0007	CcSEcCtD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor—TNF—pancreatic cancer	6.24e-05	0.00186	CbGpPWpGaD
Flutamide—Fatigue—Epirubicin—pancreatic cancer	6.2e-05	0.000694	CcSEcCtD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor—KRAS—pancreatic cancer	6.19e-05	0.00185	CbGpPWpGaD
Flutamide—Constipation—Epirubicin—pancreatic cancer	6.15e-05	0.000688	CcSEcCtD
Flutamide—AHR—Circadian rythm related genes—TP53—pancreatic cancer	6.03e-05	0.0018	CbGpPWpGaD
Flutamide—Insomnia—Doxorubicin—pancreatic cancer	6.02e-05	0.000674	CcSEcCtD
Flutamide—AR—Androgen receptor signaling pathway—CCND1—pancreatic cancer	5.94e-05	0.00177	CbGpPWpGaD
Flutamide—Feeling abnormal—Epirubicin—pancreatic cancer	5.93e-05	0.000663	CcSEcCtD
Flutamide—Somnolence—Doxorubicin—pancreatic cancer	5.92e-05	0.000662	CcSEcCtD
Flutamide—AR—Androgen receptor signaling pathway—CTNNB1—pancreatic cancer	5.88e-05	0.00176	CbGpPWpGaD
Flutamide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	5.87e-05	0.00175	CbGpPWpGaD
Flutamide—Decreased appetite—Doxorubicin—pancreatic cancer	5.79e-05	0.000647	CcSEcCtD
Flutamide—Fatigue—Doxorubicin—pancreatic cancer	5.74e-05	0.000642	CcSEcCtD
Flutamide—AR—Androgen receptor signaling pathway—PTEN—pancreatic cancer	5.74e-05	0.00171	CbGpPWpGaD
Flutamide—Constipation—Doxorubicin—pancreatic cancer	5.69e-05	0.000637	CcSEcCtD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—pancreatic cancer	5.69e-05	0.0017	CbGpPWpGaD
Flutamide—Feeling abnormal—Doxorubicin—pancreatic cancer	5.49e-05	0.000614	CcSEcCtD
Flutamide—AR—Gene Expression—CHD3—pancreatic cancer	5.34e-05	0.00159	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—MEN1—pancreatic cancer	5.34e-05	0.00159	CbGpPWpGaD
Flutamide—CYP1A1—Arachidonic acid metabolism—PTGS2—pancreatic cancer	5.32e-05	0.00159	CbGpPWpGaD
Flutamide—AR—Androgen receptor signaling pathway—SRC—pancreatic cancer	5.32e-05	0.00159	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor—HRAS—pancreatic cancer	5.26e-05	0.00157	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—RB1—pancreatic cancer	5.24e-05	0.00156	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—CDH1—pancreatic cancer	5.22e-05	0.00156	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—pancreatic cancer	5.19e-05	0.00155	CbGpPWpGaD
Flutamide—Asthenia—Epirubicin—pancreatic cancer	5.16e-05	0.000578	CcSEcCtD
Flutamide—AR—Regulation of nuclear SMAD2/3 signaling—MYC—pancreatic cancer	5.14e-05	0.00153	CbGpPWpGaD
Flutamide—AR—Androgen receptor signaling pathway—STAT3—pancreatic cancer	5.13e-05	0.00153	CbGpPWpGaD
Flutamide—Pruritus—Epirubicin—pancreatic cancer	5.09e-05	0.000569	CcSEcCtD
Flutamide—AR—Generic Transcription Pathway—NOTCH4—pancreatic cancer	5.06e-05	0.00151	CbGpPWpGaD
Flutamide—Diarrhoea—Epirubicin—pancreatic cancer	4.92e-05	0.000551	CcSEcCtD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	4.86e-05	0.00145	CbGpPWpGaD
Flutamide—Asthenia—Doxorubicin—pancreatic cancer	4.78e-05	0.000534	CcSEcCtD
Flutamide—Dizziness—Epirubicin—pancreatic cancer	4.76e-05	0.000532	CcSEcCtD
Flutamide—Pruritus—Doxorubicin—pancreatic cancer	4.71e-05	0.000527	CcSEcCtD
Flutamide—AR—Androgen receptor signaling pathway—EGFR—pancreatic cancer	4.66e-05	0.00139	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	4.65e-05	0.00139	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—SRC—pancreatic cancer	4.6e-05	0.00137	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—SRC—pancreatic cancer	4.6e-05	0.00137	CbGpPWpGaD
Flutamide—Vomiting—Epirubicin—pancreatic cancer	4.57e-05	0.000512	CcSEcCtD
Flutamide—Diarrhoea—Doxorubicin—pancreatic cancer	4.55e-05	0.00051	CcSEcCtD
Flutamide—Rash—Epirubicin—pancreatic cancer	4.54e-05	0.000508	CcSEcCtD
Flutamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	4.53e-05	0.00135	CbGpPWpGaD
Flutamide—Dermatitis—Epirubicin—pancreatic cancer	4.53e-05	0.000507	CcSEcCtD
Flutamide—Headache—Epirubicin—pancreatic cancer	4.51e-05	0.000504	CcSEcCtD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—pancreatic cancer	4.48e-05	0.00134	CbGpPWpGaD
Flutamide—AR—Gene Expression—NR5A2—pancreatic cancer	4.47e-05	0.00133	CbGpPWpGaD
Flutamide—AR—Coregulation of Androgen receptor activity—AKT1—pancreatic cancer	4.47e-05	0.00133	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—pancreatic cancer	4.43e-05	0.00132	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—RB1—pancreatic cancer	4.41e-05	0.00132	CbGpPWpGaD
Flutamide—Dizziness—Doxorubicin—pancreatic cancer	4.4e-05	0.000493	CcSEcCtD
Flutamide—CYP2C19—Arachidonic acid metabolism—PTGS2—pancreatic cancer	4.36e-05	0.0013	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—NOTCH3—pancreatic cancer	4.3e-05	0.00128	CbGpPWpGaD
Flutamide—Nausea—Epirubicin—pancreatic cancer	4.27e-05	0.000478	CcSEcCtD
Flutamide—Vomiting—Doxorubicin—pancreatic cancer	4.23e-05	0.000474	CcSEcCtD
Flutamide—Rash—Doxorubicin—pancreatic cancer	4.2e-05	0.00047	CcSEcCtD
Flutamide—Dermatitis—Doxorubicin—pancreatic cancer	4.19e-05	0.000469	CcSEcCtD
Flutamide—Headache—Doxorubicin—pancreatic cancer	4.17e-05	0.000467	CcSEcCtD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—MYC—pancreatic cancer	4.12e-05	0.00123	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—pancreatic cancer	4.11e-05	0.00123	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—CXCL8—pancreatic cancer	4.07e-05	0.00121	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—pancreatic cancer	4.03e-05	0.0012	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—pancreatic cancer	4.03e-05	0.0012	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—CASP3—pancreatic cancer	4e-05	0.00119	CbGpPWpGaD
Flutamide—Nausea—Doxorubicin—pancreatic cancer	3.95e-05	0.000442	CcSEcCtD
Flutamide—AR—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	3.9e-05	0.00116	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—CCND1—pancreatic cancer	3.89e-05	0.00116	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—CTNNB1—pancreatic cancer	3.86e-05	0.00115	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—pancreatic cancer	3.84e-05	0.00115	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—TNF—pancreatic cancer	3.84e-05	0.00115	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—pancreatic cancer	3.81e-05	0.00114	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—PTEN—pancreatic cancer	3.76e-05	0.00112	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	3.76e-05	0.00112	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—pancreatic cancer	3.63e-05	0.00108	CbGpPWpGaD
Flutamide—CYP1A1—PPARA activates gene expression—PPARG—pancreatic cancer	3.6e-05	0.00107	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	3.57e-05	0.00107	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—pancreatic cancer	3.56e-05	0.00106	CbGpPWpGaD
Flutamide—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—pancreatic cancer	3.52e-05	0.00105	CbGpPWpGaD
Flutamide—CYP1A2—Arachidonic acid metabolism—PTGS2—pancreatic cancer	3.39e-05	0.00101	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—VEGFA—pancreatic cancer	3.39e-05	0.00101	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	3.31e-05	0.000989	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	3.31e-05	0.000986	CbGpPWpGaD
Flutamide—AR—Androgen receptor signaling pathway—AKT1—pancreatic cancer	3.31e-05	0.000986	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—SMAD4—pancreatic cancer	3.24e-05	0.000967	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—pancreatic cancer	3.24e-05	0.000966	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	3.23e-05	0.000962	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	3.19e-05	0.000953	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—MYC—pancreatic cancer	3.12e-05	0.000932	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	3.11e-05	0.000929	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—EGFR—pancreatic cancer	3.05e-05	0.000911	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—SRC—pancreatic cancer	2.93e-05	0.000875	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—pancreatic cancer	2.93e-05	0.000875	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	2.89e-05	0.000861	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—KRAS—pancreatic cancer	2.89e-05	0.000861	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PRSS1—pancreatic cancer	2.88e-05	0.00086	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—pancreatic cancer	2.86e-05	0.000853	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—TNF—pancreatic cancer	2.83e-05	0.000845	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—pancreatic cancer	2.82e-05	0.000842	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	2.81e-05	0.000839	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—MYC—pancreatic cancer	2.63e-05	0.000784	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—pancreatic cancer	2.62e-05	0.000783	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	2.59e-05	0.000772	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	2.58e-05	0.00077	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—pancreatic cancer	2.57e-05	0.000767	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—pancreatic cancer	2.57e-05	0.000767	CbGpPWpGaD
Flutamide—AR—Gene Expression—MEN1—pancreatic cancer	2.57e-05	0.000767	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—TP53—pancreatic cancer	2.56e-05	0.000765	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	2.53e-05	0.000755	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—ARG2—pancreatic cancer	2.5e-05	0.000746	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—pancreatic cancer	2.45e-05	0.000731	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—pancreatic cancer	2.45e-05	0.000731	CbGpPWpGaD
Flutamide—AR—Gene Expression—NOTCH4—pancreatic cancer	2.44e-05	0.000727	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—pancreatic cancer	2.43e-05	0.000725	CbGpPWpGaD
Flutamide—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—pancreatic cancer	2.43e-05	0.000724	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	2.41e-05	0.000719	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	2.39e-05	0.000713	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—NOTCH1—pancreatic cancer	2.39e-05	0.000713	CbGpPWpGaD
Flutamide—AR—Gene Expression—HSPA1B—pancreatic cancer	2.32e-05	0.000693	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—PPARG—pancreatic cancer	2.25e-05	0.000673	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	2.2e-05	0.000655	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—TYMP—pancreatic cancer	2.18e-05	0.000652	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—AKT1—pancreatic cancer	2.17e-05	0.000646	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	2.12e-05	0.000634	CbGpPWpGaD
Flutamide—AR—Gene Expression—EZH2—pancreatic cancer	2.12e-05	0.000631	CbGpPWpGaD
Flutamide—AR—Gene Expression—NOTCH3—pancreatic cancer	2.07e-05	0.000618	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—pancreatic cancer	2.07e-05	0.000616	CbGpPWpGaD
Flutamide—AR—Gene Expression—HSPA1A—pancreatic cancer	1.96e-05	0.000585	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PRSS1—pancreatic cancer	1.88e-05	0.000561	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.8e-05	0.000538	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	1.79e-05	0.000535	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PRSS1—pancreatic cancer	1.78e-05	0.00053	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—GLP1R—pancreatic cancer	1.76e-05	0.000525	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—DPYD—pancreatic cancer	1.73e-05	0.000517	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—SLC2A2—pancreatic cancer	1.64e-05	0.00049	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ARG2—pancreatic cancer	1.63e-05	0.000486	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.63e-05	0.000485	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.57e-05	0.000468	CbGpPWpGaD
Flutamide—AR—Gene Expression—SMAD4—pancreatic cancer	1.56e-05	0.000465	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ARG2—pancreatic cancer	1.54e-05	0.000459	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PRSS1—pancreatic cancer	1.45e-05	0.000433	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.43e-05	0.000427	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—TYMP—pancreatic cancer	1.42e-05	0.000425	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—TYMP—pancreatic cancer	1.35e-05	0.000401	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—MYC—pancreatic cancer	1.29e-05	0.000383	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—CD44—pancreatic cancer	1.27e-05	0.00038	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ARG2—pancreatic cancer	1.26e-05	0.000376	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.25e-05	0.000372	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.24e-05	0.000369	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—GCG—pancreatic cancer	1.22e-05	0.000364	CbGpPWpGaD
Flutamide—AR—Gene Expression—NOTCH1—pancreatic cancer	1.15e-05	0.000343	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GLP1R—pancreatic cancer	1.15e-05	0.000342	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—STK11—pancreatic cancer	1.15e-05	0.000342	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PRSS1—pancreatic cancer	1.13e-05	0.000338	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—DPYD—pancreatic cancer	1.13e-05	0.000337	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.11e-05	0.000331	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—TYMP—pancreatic cancer	1.1e-05	0.000328	CbGpPWpGaD
Flutamide—AR—Gene Expression—PPARG—pancreatic cancer	1.09e-05	0.000324	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GLP1R—pancreatic cancer	1.08e-05	0.000324	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.08e-05	0.000321	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—SLC2A2—pancreatic cancer	1.07e-05	0.00032	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—DPYD—pancreatic cancer	1.07e-05	0.000318	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—SLC2A2—pancreatic cancer	1.01e-05	0.000302	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1e-05	0.000299	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—TYMS—pancreatic cancer	9.87e-06	0.000295	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ARG2—pancreatic cancer	9.82e-06	0.000293	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	9.67e-06	0.000288	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	9.09e-06	0.000271	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GLP1R—pancreatic cancer	8.88e-06	0.000265	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	8.81e-06	0.000263	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PRSS1—pancreatic cancer	8.74e-06	0.000261	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—DPYD—pancreatic cancer	8.73e-06	0.00026	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—TYMP—pancreatic cancer	8.58e-06	0.000256	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CD44—pancreatic cancer	8.3e-06	0.000248	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—SLC2A2—pancreatic cancer	8.29e-06	0.000247	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	8.2e-06	0.000245	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—APOE—pancreatic cancer	8.03e-06	0.00024	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GCG—pancreatic cancer	7.96e-06	0.000237	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	7.91e-06	0.000236	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CD44—pancreatic cancer	7.84e-06	0.000234	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	7.68e-06	0.000229	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	7.61e-06	0.000227	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	7.6e-06	0.000227	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ARG2—pancreatic cancer	7.58e-06	0.000226	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GCG—pancreatic cancer	7.52e-06	0.000224	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—STK11—pancreatic cancer	7.48e-06	0.000223	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PIK3CG—pancreatic cancer	7.25e-06	0.000216	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	7.21e-06	0.000215	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	7.08e-06	0.000211	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—STK11—pancreatic cancer	7.07e-06	0.000211	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PPARG—pancreatic cancer	6.99e-06	0.000209	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GLP1R—pancreatic cancer	6.92e-06	0.000206	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—DPYD—pancreatic cancer	6.8e-06	0.000203	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	6.63e-06	0.000198	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—TYMP—pancreatic cancer	6.62e-06	0.000198	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	6.46e-06	0.000193	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—TYMS—pancreatic cancer	6.44e-06	0.000192	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CD44—pancreatic cancer	6.42e-06	0.000191	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	6.39e-06	0.000191	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PIK3CD—pancreatic cancer	6.37e-06	0.00019	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	6.28e-06	0.000187	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	6.23e-06	0.000186	CbGpPWpGaD
Flutamide—AR—Gene Expression—MYC—pancreatic cancer	6.19e-06	0.000185	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	6.17e-06	0.000184	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GCG—pancreatic cancer	6.15e-06	0.000184	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—TYMS—pancreatic cancer	6.08e-06	0.000181	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—STK11—pancreatic cancer	5.78e-06	0.000173	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	5.62e-06	0.000168	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PIK3CB—pancreatic cancer	5.55e-06	0.000166	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PTGS2—pancreatic cancer	5.5e-06	0.000164	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	5.43e-06	0.000162	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GLP1R—pancreatic cancer	5.34e-06	0.000159	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—DPYD—pancreatic cancer	5.25e-06	0.000157	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—APOE—pancreatic cancer	5.23e-06	0.000156	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CD44—pancreatic cancer	5e-06	0.000149	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	4.98e-06	0.000149	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—TYMS—pancreatic cancer	4.98e-06	0.000148	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—APOE—pancreatic cancer	4.94e-06	0.000148	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	4.9e-06	0.000146	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	4.85e-06	0.000145	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PTEN—pancreatic cancer	4.8e-06	0.000143	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GCG—pancreatic cancer	4.79e-06	0.000143	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PIK3CG—pancreatic cancer	4.72e-06	0.000141	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.68e-06	0.00014	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PPARG—pancreatic cancer	4.56e-06	0.000136	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—STK11—pancreatic cancer	4.51e-06	0.000134	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PIK3CG—pancreatic cancer	4.46e-06	0.000133	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PPARG—pancreatic cancer	4.31e-06	0.000128	CbGpPWpGaD
Flutamide—AR—Gene Expression—AKT1—pancreatic cancer	4.29e-06	0.000128	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.23e-06	0.000126	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PIK3CD—pancreatic cancer	4.15e-06	0.000124	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—APOE—pancreatic cancer	4.05e-06	0.000121	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PIK3CD—pancreatic cancer	3.92e-06	0.000117	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—TYMS—pancreatic cancer	3.88e-06	0.000116	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CD44—pancreatic cancer	3.86e-06	0.000115	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.83e-06	0.000114	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GCG—pancreatic cancer	3.7e-06	0.00011	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	3.65e-06	0.000109	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PIK3CB—pancreatic cancer	3.62e-06	0.000108	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PTGS2—pancreatic cancer	3.59e-06	0.000107	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PPARG—pancreatic cancer	3.52e-06	0.000105	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—STK11—pancreatic cancer	3.48e-06	0.000104	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PIK3CB—pancreatic cancer	3.42e-06	0.000102	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PTGS2—pancreatic cancer	3.39e-06	0.000101	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PIK3CA—pancreatic cancer	3.38e-06	0.000101	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	3.21e-06	9.58e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—APOE—pancreatic cancer	3.15e-06	9.41e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PTEN—pancreatic cancer	3.13e-06	9.33e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—TYMS—pancreatic cancer	2.99e-06	8.92e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.98e-06	8.9e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PTEN—pancreatic cancer	2.95e-06	8.81e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	2.85e-06	8.49e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	2.8e-06	8.35e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PTGS2—pancreatic cancer	2.77e-06	8.27e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—AKT1—pancreatic cancer	2.77e-06	8.25e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PPARG—pancreatic cancer	2.75e-06	8.19e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	2.5e-06	7.46e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—APOE—pancreatic cancer	2.43e-06	7.26e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PTEN—pancreatic cancer	2.42e-06	7.21e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PIK3CA—pancreatic cancer	2.21e-06	6.58e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	2.2e-06	6.55e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	2.18e-06	6.5e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PTGS2—pancreatic cancer	2.16e-06	6.44e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PPARG—pancreatic cancer	2.12e-06	6.32e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PIK3CA—pancreatic cancer	2.08e-06	6.22e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	1.93e-06	5.76e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PTEN—pancreatic cancer	1.88e-06	5.62e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—AKT1—pancreatic cancer	1.8e-06	5.38e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	1.71e-06	5.09e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—AKT1—pancreatic cancer	1.7e-06	5.08e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	1.68e-06	5.02e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PTGS2—pancreatic cancer	1.67e-06	4.97e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.45e-06	4.34e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—AKT1—pancreatic cancer	1.39e-06	4.16e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	1.33e-06	3.96e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—AKT1—pancreatic cancer	1.09e-06	3.24e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.03e-06	3.06e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—AKT1—pancreatic cancer	8.38e-07	2.5e-05	CbGpPWpGaD
